Cleveland OH 小细胞肺癌临床试验
13项针对 小细胞肺癌的研究正在 Cleveland及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
招募中2 期
- University Hospitals Cleveland Medical Center /ID# 277556, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- The Cleveland Clinic Taussig Cancer Center, Cleveland
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
招募中2/3 期
- University Hospitals Cleveland Medical Center, Cleveland
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
招募中1/2 期
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中1/2 期
- University Hospitals Cleveland Medical Center, Cleveland
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
招募中3 期
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic - Fairview Hospital Molly Pavilion, Cleveland
- Cleveland Clinic, Cleveland
- 以及另外 1 项
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
招募中3 期
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion, Cleveland
- Cleveland Clinic Foundation, Cleveland
- 以及另外 1 项
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
招募中1/2 期
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
招募中2 期
- University Hospital - Cleveland Medical Center, Cleveland
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
招募中2 期
- Cleveland Clinic, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- Cleveland Clinic, Cleveland
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
招募中1 期
- Case Comprehensive Cancer Center, Cleveland
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
招募中1 期
- Zelgen Site 104, Cleveland
其他城市的 小细胞肺癌试验
- Houston, TX26 项研究
- Arlington, VA23 项研究
- New York City, NY22 项研究
- Boston, MA21 项研究
- Nashville, TN20 项研究
- Los Angeles, CA20 项研究
- Orlando, FL15 项研究
- Dallas, TX13 项研究
- Chicago, IL13 项研究
- St. Louis, MO13 项研究
- Detroit, MI12 项研究
- Washington, DC12 项研究
Cleveland的其他研究
- 非小细胞肺癌43 项研究
- 癌症（所有类型）36 项研究
- 乳腺癌35 项研究
- 前列腺癌34 项研究
- 心力衰竭33 项研究
- 卵巢癌30 项研究
- 转移性癌症30 项研究
- 肺癌26 项研究
- 结直肠癌24 项研究
- 心血管疾病22 项研究
- 子宫内膜癌20 项研究
- 急性髓系白血病20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。